RecallWatchUSA

Home / Brands / Edge Pharma

Edge Pharma Recalls

62 recalls on record · September 16, 2020 to February 2, 2022 · Drugs

Recalls by year

20
21
22

Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.

February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Trypan Blue 0.03%, 0.5mL per syringe, Sterile Ophthalmic Solution for Injection Preservative Free, Single Use Syringe, F
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL per syringe, Single Dose Syringe for Oral Use Only, E
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Tetracaine HCl Nasal Solution, 4%, 240 mL per bottle, Multiple Dose Container for Intranasal Use, Edge Pharma, LLC, 856
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Promethazine HCl Topical Ointment, 2.5% (25 mg/mL), 1.2 mL per syringe, Single Dose Syreinge for Topical Use Only, Edge
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vitamin K (Vitamin K ) Oral Solution (PF), 5 mg/mL, 1mL per syringe, single Dose Syringe for Oral Use, Edge Pharma, LLC,
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL per vial, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Profound-PE Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl/Phenylephrine, 10% / 10% / 4% / 2%, Spear-Peppermint
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Profound-PE Dental Gel, Lidocaine HCl/ Prilocaine HCl/ Tetracaine HCl/ Phenylephrin HCl, 10% / 10% / 4% / 2% Raspberry-M
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10% / 10% / 4%, Spearmint-Peppermint, Multiple Dose Co
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10%/10%/4% Raspberry Marshmallow, 30 grams per jar, Mu
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Lidocaine HCl / Oxymetazoline HCl Nasal Solution, 4% / 0.05%, 240mL per bottle, Multiple Dose Container for Intranasal
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls LET Topical Gel, Lidocaine HCL / Epinepherine / Tetracaine HCl, 4%/0.05%/0.5%, 3 mL per syringe, Single Dose Syringe for
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical Use, Edge Pharma, LLC,
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Dibutyl Squaric Acid, Topical Solution (PF) Multiple Dose Vial, 1%, 10 mL per vial, Edge Parma, LLC, 856 Hercules Dr., C
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Dibutyl Squaric Acid, Topical Solution (PF), Multiple Dose Vial, 2%, 10 mL per vial, Edge Pharma, LLC, 856 Hercules Dr,
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Dexamethasone sodium phosphate 0.4%, 120 mL per bottle, Multiple Dose Container For Topical Use, Edge Pharma, LLC, 856 H
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 cou
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose Vials for Topical Use
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge Pharma, LLC, 856 Herc
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls BLT Topical Cream, Benzocaine/Lidocaine/Tetracaine, 20%/8%/4%, 60gm per jar, Multiple Dose Container For Topical Use, Ed
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag for IV Injection (Preservative Free
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Injection (Preservative Fr
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag for IV Injection (Preservative F
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl, Sterile Ophthalmic Solution for Injection, Preservative Free, 8 mg/0.8mL (10 mg/mL) (vancomycin equivale
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL per syringe, Single Use Syringe, Fo
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/ Ketorolac Sterile Ophthalmic Solution, 10%/ 0.25%/ 0.25%/0.125%, 10 mL
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0.25%/0.125%, 0.5 mL
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL per dropper, Multiple Dose Droptainer for Top
Hazard: Lack of Assurance of Sterility
Edge Pharma Recalls | RecallWatchUSA